Ads
related to: genetic mutation cancer- Dosing & Administration
Find Dose Modification & Admin
Information For A Targeted Therapy.
- NTRK+ Gene Fusion Cancer
When Present, NTRK+ Gene Fusion Is
Often The Primary Oncogenic Driver.
- Downloadable Resources
Find Helpful Resources For Your
Patients & Practice Today.
- Important Safety Info
Find Full Safety And
Prescribing Information Here.
- Dosing & Administration
Search results
Study Shows Polygenic Risk Score (PGS) Could Predi | Newswise
Newswise· 2 days agoData from a large prospective cohort study reveal that a polygenic risk score has the potential to...
Human Longevity Startup Matter Bio Raises $7M in Seed Funding
GenomeWeb News· 2 days agoThe Brooklyn-based company said it also has grant support from the National Institutes of Health. Matter Bio is a holding company for three biotechs: MutagenTech, which is investigating the ...
The Most Profitable Biotechnology Company in the World
Insider Monkey via Yahoo Finance· 6 hours agoIn this article, we will be taking a look at the most profitable biotechnology company in the world. If you want to learn about more, head straight to the 15 Most Profitable Biotechnology Companies ...
Researchers studying causes of lung cancer in Asian women who never smoked
NBC Chicago· 2 days agoResearchers and doctors have been left baffled after a recent study found more than 50% of Asian...
Local woman regains her health after groundbreaking first of its kind surgery in West Virginia
WTRF Wheeling· 2 days agoMORGANTOWN, W.Va. – An Ohio Valley woman is the first to receive a groundbreaking surgery, the first...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 hours agoTruqap™ (capivasertib) plus fulvestrant now available in Canada Canada NewsWire MISSISSAUGA, ON, May 31, 2024 MISSISSAUGA, ON, May 31, 2024 /CNW/ - AstraZeneca is pleased to announce that Truqap™ (capivasertib) in combination with fulvestrant is
U.K. Army Nearly Rejects Healthy Teen Because Her Relatives Had Cancer
Forbes· 7 days agoThe British army is under fire for having almost rejected a teenager on the grounds she has...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 24 hours agoNext-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN’s QIAseq xHYB technology, QIAGEN Digital Insight solutions, and Myriad’s proprietary, FDA-approved MyChoice CDx® biomarkers QIAGEN to make kit-based
How AI is enhancing health care
Dallas Morning News· 2 days agoArtificial intelligence is rapidly reshaping the landscape of health care, revolutionizing scientific discovery, drug development, diagnosis and...
Summer is here! Your need-to-know sunscreen guide
KHON 2 Honolulu· 4 days agoIt’s National Sunscreen Day, and it’s the unofficial start to summer. So, KHON2.com decided to give you a few pointers on how to select sunscreens for...
Ad
related to: genetic mutation cancer